Skip to main content

Table 2 Adverse events associated with intralymphatic injections

From: Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial

 

Active ILIT (61 injections)

Placebo ILIT (45 injections)

 

Early Reactions

Late Reactions

Early Reactions

Late Reactions

Local Lymph Node Swelling

Mild: 6

Mild: 14

Mild: 1

Mild: 1

Moderate: 0

Moderate: 0

Moderate: 0

Moderate: 0

Severe: 0

Severe: 0

Severe: 0

Severe: 0

Local Itch

Mild: 6

Mild: 11

Mild: 2

Mild: 1

Moderate: 0

Moderate: 0

Moderate: 0

Moderate: 0

Severe: 0

Severe: 0

Severe: 0

Severe: 0

Local Redness

Mild: 11

Mild: 21

Mild: 0

Mild: 0

Moderate: 0

Moderate: 0

Moderate: 0

Moderate: 0

Severe: 0

Severe: 0

Severe: 0

Severe: 0

Nasal Symptoms

Mild: 1

Mild: 1

Mild: 4

Mild: 4

Moderate: 0

Moderate: 0

Moderate: 0

Moderate:0

Severe: 0

Severe: 0

Severe: 0

Severe: 0

Pulmonary Symptoms

Mild: 0

Mild: 0

Mild: 0

Mild: 0

Moderate: 0

Moderate: 0

Moderate: 0

Moderate: 0

Severe: 0

Severe: 0

Severe: 0

Severe: 0

Urticaria and angiooedema

Mild: 1

Mild: 4

Mild: 0

Mild: 1

Moderate: 0

Moderate: 0

Moderate: 0

Moderate: 0

Severe: 0

Severe: 0

Severe: 0

Severe: 0

Abdominal Symptoms

Mild: 0

Mild: 1

Mild: 0

Mild: 1

Moderate: 0

Moderate: 0

Moderate: 0

Moderate: 0

Severe: 0

Severe: 0

Severe: 0

Severe: 0